about
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic HepatitisHepatitis E virus persists in the presence of a type III interferon response.Rabbit Hepatitis E Virus Infections in Humans, France.Hepatitis E virus infections in blood donors, France.Hepatitis E in Transplantation.HEV infection in French HIV-infected patients.HEV and transfusion-recipient risk.Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response.Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient.Quantification of HEV RNA by Droplet Digital PCR.Detection of Hepatitis E Virus in Sewage After an Outbreak on a French Island.Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections.Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients.Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients.Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.No evidence of genotype-3 hepatitis E virus-induced myocarditis.Hepatitis E virus.Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine.Viral load and clinical manifestations of hepatitis E virus genotype 3 infections
P50
Q26740390-959FE064-EF82-44A5-B7B0-D42A066A7640Q30100969-84290E9A-CC6C-4683-93E4-D6630CE7B9BFQ33908103-B081512B-B8F5-47F1-B228-1BC3D40EC06DQ34426715-E63F050C-21B8-415C-8A05-8EE6D73EE229Q38720607-BDAD52B9-B3F1-45D8-9B4C-45A7027BF924Q39081278-00F18B11-659C-4C5C-AEB8-DAF6F88BF8FBQ40130228-7EE3BB87-16BE-41A0-8E23-DEF78FBCD51AQ40209884-5B48328C-2522-4D26-B6C5-89EB9F32F0C0Q40229301-CD503E5E-C1A3-4E92-81DD-94B9941BA0C6Q40399326-49CD3B56-00BC-425B-9F93-77D743B5B9A3Q40679962-49A654F7-AE1C-4839-8EF4-38C531464FE1Q42242689-E2D80FD7-087B-4B2B-8F92-02B3A1C3C9B4Q42258240-C04FDA6F-D897-4E9D-848A-E54E545B8FB7Q42275354-31D1804A-7597-4F8A-A051-280A855FDBCCQ42938081-1830B1FE-A696-42D1-88E1-4119A537A8A9Q45338692-6A02F57B-A205-4FA2-ADF8-51AFAA51E6C4Q51051857-D13106CB-2620-4CF5-A7B8-3C8D148553AFQ52579672-BBF06C74-1F85-48C3-A728-0970C9B04B22Q54388808-3BE1EAFB-CFF9-4C71-9355-3C21339091B4Q55100910-1BD13580-8D9C-4DD5-864D-7886766B0871Q92103684-A834771F-EB45-4FA9-98AE-BABD1C522F2F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sebastien Lhomme
@ast
Sebastien Lhomme
@en
Sebastien Lhomme
@es
Sebastien Lhomme
@nl
Sebastien Lhomme
@sl
type
label
Sebastien Lhomme
@ast
Sebastien Lhomme
@en
Sebastien Lhomme
@es
Sebastien Lhomme
@nl
Sebastien Lhomme
@sl
prefLabel
Sebastien Lhomme
@ast
Sebastien Lhomme
@en
Sebastien Lhomme
@es
Sebastien Lhomme
@nl
Sebastien Lhomme
@sl
P1053
K-3199-2014
P106
P21
P31
P3829
P496
0000-0001-7908-1576